University of Cambridge > > Cambridge Oncology Seminar Series > Risk and uncertainty in radiotherapy. Why I am the weakest link?

Risk and uncertainty in radiotherapy. Why I am the weakest link?

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Mala Jayasundera.

As the patient safety agenda continues to shine the spotlight on the number of errors in clinical medicine, most radiotherapy departments can point to excellent quality assurance and incident reporting systems as evidence that we are among the safest disciplines. QA is especially important in the face of increasing physics accuracy and computational power which together mean we can deliver known doses of radiation to our target volumes and away from critical structures with millimetre accuracy. With increasingly precise radiation delivery it becomes even more important that we define our targets accurately.

This talk is part of the Cambridge Oncology Seminar Series series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity